Last €2.66 EUR
Change Today +0.019 / 0.72%
Volume 9.9K
As of 1:15 PM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

aap implantate (AAQ) Snapshot

Open
€2.59
Previous Close
€2.64
Day High
€2.70
Day Low
€2.59
52 Week High
04/3/14 - €3.65
52 Week Low
10/1/13 - €1.23
Market Cap
81.7M
Average Volume 10 Days
31.5K
EPS TTM
€-0.04
Shares Outstanding
30.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AAP IMPLANTATE (AAQ)

Related News

No related news articles were found.

aap implantate (AAQ) Related Businessweek News

No Related Businessweek News Found

aap implantate (AAQ) Details

aap Implantate AG, a medical device company, researches, develops, manufactures, and sells implants, medical instruments, bone cements, and replacement materials for use in orthopedic procedures in Germany and internationally. It provides LOQTEQ, an anatomical angular stable plating system for compressing fractures with angular stable locking screws; and fragment set comprising T, L, quarter tubular, and reconstruction plates, as well as cortical and cancellous screws. It also offers cannulated screws for the treatment of hand and foot fracture; AcroPlate, which is used for the treatment of AC joint injuries; and autodynamic plating systems for secure fracture stabilization. In addition, the company provides a range of bone cements and accessories for application in arthroplasty, vertebroplasty, and kyphoplasty; and collagen fleeces for ambulant and stationary tissue care. Further, it offers bone substitutes that includes Artosal, a synthetic osteoconductive bone substitute; Cerabone, a ceramic bone substitute; OsteoCem, a calcium phosphate cement; Osnatal, a human bone allograft; and PerOssal, a synthetic bone substitute and carrier material. The company sells its products through its direct sales force, and distribution partners, as well as through license agreements with OEM partners. aap Implantate AG is headquartered in Berlin, Germany.

195 Employees
Last Reported Date: 08/14/14

aap implantate (AAQ) Top Compensated Officers

Chairman of Management Board and Chief Execut...
Total Annual Compensation: €381.0K
Chief Finance Officer and Member of the Manag...
Total Annual Compensation: €260.0K
Compensation as of Fiscal Year 2013.

aap implantate (AAQ) Key Developments

aap Implantate AG Announces Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Provides Earnings Guidance for the Third Quarter and Full Year 2014

aap Implantate AG announced earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported net income of EUR 940,000 or EUR 0.03 per share compared to EUR 156,000 or EUR 0.01 per share a year ago. Total revenue was EUR 8.39 million compared to EUR 9.14 million a year ago. For the six months, the company reported net income of EUR 572,000 or EUR 0.02 per share compared to EUR 2.28 million or EUR 0.07 per share a year ago. Total revenue was EUR 17.03 million compared to EUR 19.81 million a year ago. For the third quarter of 2014, the company expects net sales to be in the range of EUR 7 million to EUR 8 million and EBITDA to be in the range of EUR 0 million to EUR 400,000. For the year 2014, the company expects total sales to be EUR 35 million and EBITDA to be in the range of EUR 5 million to EUR 6 million.

AAP Implantate AG, Q2 2014 Earnings Call, Aug 14, 2014

AAP Implantate AG, Q2 2014 Earnings Call, Aug 14, 2014

AAP Implantate AG Reports Sales Results for the Second Quarter and Six Months of 2014

AAP Implantate AG reported sales results for the second quarter and six months of 2014. For the quarter, the company reported sales from continued operations of EUR 8.0 million against EUR 6.6 million a year ago. For the six months, the company reported sales from continued operations of EUR 14.2 million against EUR 12.6 million a year ago. Total sales were EUR 15.2 million against EUR 19.6 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AAQ:GR €2.66 EUR +0.019

AAQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AAQ.
View Industry Companies
 

Industry Analysis

AAQ

Industry Average

Valuation AAQ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.4x
Price/Book 1.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AAP IMPLANTATE, please visit www.aap.de. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.